RYR2 and catecholaminergic polymorphic ventricular tachycardia: Few RyR2 mutations have already been characterized in CM derived from induced pluripotent stem cells (iPSCs) and reflect basic aspects of CPVT that can be assessed well on the single-cell level38–45.